Catalent Inc. (CTLT)
63.48
0.00 (0.00%)
At close: Dec 17, 2024, 9:00 PM
Catalent Inc. Revenue Breakdown
| Quarter | Sep 30, 2024 | Jun 30, 2024 | Mar 31, 2024 | Dec 31, 2023 | Sep 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 | Dec 31, 2020 | Sep 30, 2020 | Jun 30, 2020 | Mar 31, 2020 | Dec 31, 2019 | Sep 30, 2019 | Jun 30, 2019 | Mar 31, 2019 | Dec 31, 2018 | Sep 30, 2018 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Biologics Revenue | 461M | 605M | 461M | 438M | 448M | 475M | 580M | 523M | 667M | 698M | 638M | 546M | 603.3M | 543.7M | 403.9M | 377.1M | 357.8M | 250M | 225.2M | 188.6M | 231.1M | 172.1M | 184.3M | 154.6M |
| Biologics Revenue Growth | -23.80% | +31.24% | +5.25% | -2.23% | -5.68% | -18.10% | +10.90% | -21.59% | -4.44% | +9.40% | +16.85% | -9.50% | +10.96% | +34.61% | +7.11% | +5.39% | +43.12% | +11.01% | +19.41% | -18.39% | +34.28% | -6.62% | +19.21% | n/a |
| PharmaConsumerHealth Revenue | 563M | 697M | 613M | 587M | 534M | 563M | 570M | 499M | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
| PharmaConsumerHealth Revenue Growth | -19.23% | +13.70% | +4.43% | +9.93% | -5.15% | -1.23% | +14.23% | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Revenue by Geography
| Quarter | Jun 30, 2024 | Jun 30, 2022 | Jun 30, 2021 | Jun 30, 2020 | Jun 30, 2019 | Jun 30, 2018 | Jun 30, 2017 | Jun 30, 2016 | Jun 30, 2015 | Jun 30, 2014 |
|---|---|---|---|---|---|---|---|---|---|---|
| Europe Revenue | 1.36B | 1.51B | 1.34B | 976.1M | 842.1M | 897.8M | 797.4M | 733.2M | 795.4M | 888.8M |
| Europe Revenue Growth | -9.76% | +12.14% | +37.59% | +15.91% | -6.20% | +12.59% | +8.76% | -7.82% | -10.51% | n/a |
| United States Revenue | 2.82B | 3.11B | 2.46B | n/a | n/a | 1.22B | 996.4M | 858.6M | 799.3M | 682.3M |
| United States Revenue Growth | -9.23% | +26.32% | n/a | n/a | n/a | +22.42% | +16.05% | +7.42% | +17.15% | n/a |